Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)
Close on Nov 17, 2026Market cap $1.89BP/E –Yield –
Fortrea gross margin
Gross margin is gross profit as a percentage of revenue.
Fortrea's gross margin for the twelve months ending Sep 30, 2026 was 20.0%. For fiscal 2025 it was 18.5%, against 19.8% the year before. The highest annual figure on record is 25.5% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.5% | −1.3 |
| FY2024 | Dec 31, 2024 | 19.8% | −1.0 |
| FY2023 | Dec 31, 2023 | 20.8% | −4.8 |
| FY2022 | Dec 31, 2022 | 25.5% | +5.8 |
| FY2021 | Dec 31, 2021 | 19.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 20.2% | +2.7 |
| Q2 FY2026 | Jun 30, 2026 | 20.5% | +1.7 |
| Q1 FY2026 | Mar 31, 2026 | 19.4% | +1.5 |
| Q4 FY2025 | Dec 31, 2025 | 19.8% | −0.4 |
| Q3 FY2025 | Sep 30, 2025 | 17.5% | −4.5 |
| Q2 FY2025 | Jun 30, 2025 | 18.8% | −1.9 |
| Q1 FY2025 | Mar 31, 2025 | 17.9% | +1.6 |
| Q4 FY2024 | Dec 31, 2024 | 20.2% | +1.6 |
| Q3 FY2024 | Sep 30, 2024 | 22.0% | +1.0 |
| Q2 FY2024 | Jun 30, 2024 | 20.7% | −0.9 |
| Q1 FY2024 | Mar 31, 2024 | 16.3% | −5.7 |
| Q4 FY2023 | Dec 31, 2023 | 18.6% | −28.7 |
| Q3 FY2023 | Sep 30, 2023 | 21.0% | −1.0 |
| Q2 FY2023 | Jun 30, 2023 | 21.6% | −1.0 |
| Q1 FY2023 | Mar 31, 2023 | 22.0% | – |
| Q4 FY2022 | Dec 31, 2022 | 47.3% | – |
| Q3 FY2022 | Sep 30, 2022 | 22.0% | – |
| Q2 FY2022 | Jun 30, 2022 | 22.5% | – |
See a number that looks wrong?